Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. CRL

Go back to Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline
Merck & Co. (NYSE: MRK) Delayed: 148.78 +0.80 (0.54%)
Previous Close $147.98    52 Week High $65.46 
Open $148.06    52 Week Low $47.97 
Day High $149.98    P/E 101.21 
Day Low $147.48    EPS $1.47 
Volume 8,290,254